Document Detail

Angiotensin-converting enzyme insertion/deletion polymorphism is a risk factor for thoracic aortic aneurysm in patients with bicuspid or tricuspid aortic valves.
MedLine Citation:
PMID:  22245237     Owner:  NLM     Status:  Publisher    
OBJECTIVE: The angiotensin-converting enzyme (ACE) is highly expressed in the aneurysmal vascular wall, in both animal models and human disease. Genetic variations in ACE could be crucial in determining the risk of thoracic aortic aneurysm (TAA). The aim of the present study was to examine the role of ACE insertion/deletion polymorphism on the risk of TAA in patients with bicuspid aortic valves or tricuspid aortic valves. METHODS: We enrolled 216 patients (158 men; age, 58.9 ± 14.9 years) with TAA, associated with bicuspid aortic valves (n = 105) and tricuspid aortic valves (n = 111) compared with 312 patients (252 men; age, 54.6 ± 11.0 years) with angiographically proven coronary artery disease and 300 healthy controls (91 men; age, 40.4 ± 10.5 years). RESULTS: The genotype distribution of ACE insertion/deletion was significantly different between the patients with TAA compared with both the control group (P = .0005) and the coronary artery disease group (P = .03). The genotypes were not different between the control group and the coronary artery disease group (P = .3). Compared with the controls, both the bicuspid aortic valve patients (P = .0008) and tricuspid aortic valve patients (P < .0001) had a greater frequency of allele D. The aortic diameters were significantly different among the three genotypes (48.3 ± 6.6, 45.3 ± 8.9, 39.9 ± 8.7 for the DD, DI, and II genotypes, respectively; P = .0002). A synergistic effect between the ACE D allele and hypertension was found for both an increased aortic diameter (P = .003) and the risk of TAA (P < .001). On multivariate logistic regression analysis, D allele (odds ratio, 3.0; 95% confidence interval, 1.1-8.1; P = .03) was a significant predictor of TAA. CONCLUSIONS: ACE insertion/deletion polymorphism represents a genetic biomarker for TAA. These findings could have a significant effect on both the early detection and effective pharmacologic treatment of aortic disease.
Ilenia Foffa; Michele Murzi; Massimiliano Mariani; Anna Maria Mazzone; Mattia Glauber; Lamia Ait Ali; Maria Grazia Andreassi
Related Documents :
21934497 - Lipid-lowering therapy and coronary artery bypass graft surgery: what are the benefits?
22155117 - Emergent angioplasty and stent placement recanalization without thrombolysis in acute m...
22112797 - Long-term outcome of direct neopulmonary artery reconstruction during the arterial swit...
15337867 - Initial management and outcome of aortic endograft limb occlusion.
24607377 - In situ total aortic arch replacement for infected distal aortic arch aneurysms with pe...
3178357 - Left atrial tumor embolization during pulmonary resection: review of literature and rep...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-1-13
Journal Detail:
Title:  The Journal of thoracic and cardiovascular surgery     Volume:  -     ISSN:  1097-685X     ISO Abbreviation:  -     Publication Date:  2012 Jan 
Date Detail:
Created Date:  2012-1-16     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0376343     Medline TA:  J Thorac Cardiovasc Surg     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2012 The American Association for Thoracic Surgery. Published by Mosby, Inc. All rights reserved.
CNR Institute of Clinical Physiology, Pisa, Italy; Scuola Superiore Sant'Anna, Pisa, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Association of IL28B gene polymorphism with development of hepatocellular carcinoma in Japanese pati...
Next Document:  Bilateral internal thoracic artery grafting improves long-term survival in patients with reduced eje...